Assenagon Asset Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-286,644
| Closed | -$3.81M | – | 1354 |
|
|
2023
Q4 | $3.81M | Sell |
286,644
-434,830
| -60% | -$5.78M | 0.01% | 686 |
|
|
2023
Q3 | $6.46M | Buy |
721,474
+142,083
| +25% | +$1.27M | 0.02% | 484 |
|
|
2023
Q2 | $6.52M | Buy |
579,391
+540
| +0.1% | +$6.08K | 0.02% | 417 |
|
|
2023
Q1 | $6.67M | Buy |
578,851
+315,825
| +120% | +$3.64M | 0.02% | 474 |
|
|
2022
Q4 | $3.05M | Hold |
263,026
| – | – | 0.01% | 645 |
|
|
2022
Q3 | $3.34M | Sell |
263,026
-3,586
| -1% | -$45.5K | 0.01% | 553 |
|
|
2022
Q2 | $1.83M | Sell |
266,612
-28,617
| -10% | -$197K | 0.01% | 841 |
|
|
2022
Q1 | $2.85M | Sell |
295,229
-66,704
| -18% | -$643K | 0.01% | 671 |
|
|
2021
Q4 | $4.3M | Buy |
+361,933
| New | +$4.3M | 0.01% | 535 |
|